Výsledky vyhledávání

Akademický článek

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial.

Autor: Harrison TW (AUTHOR), Oborne J (AUTHOR), Newton S (AUTHOR), Tattersfield AE (AUTHOR), Harrison, T W¹ (AUTHOR), Oborne, J (AUTHOR), Newton, S (AUTHOR), Tattersfield, A E (AUTHOR)

Publikováno v: Lancet. 1/24/2004, Vol. 363 Issue 9405, p271-275. 5p.

Zobrazit plný text záznamu

Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial

Autor: Mckeever, T, Mortimer, K, Duley, L, Bradshaw, L, Swinden, R, Skeggs, A, Pavord, I, Higgins, B, Walker, S, Thomas, M, Devereux, G, Wilson, A, Brightling, C, Price, D, Oborne, J, Mitchell, E, Harrison, T, Haydock, R

Asthma exacerbations are frightening for patients and are occasionally fatal. We tested the concept that a self-management plan, which included a temporary quadrupling of the dose of inhaled corticosteroid when asthma control starts to deteriorate, w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::006387b88c8b448f75ea9e7bf40e1ddf
https://doi.org/10.1183/1393003.congress-2017.pa1367

Zobrazit plný text záznamu

Randomised placebo controlled trial of β agonist dose reduction in asthma

Autor: Harrison, T, Oborne, J, Wilding, P, Tattersfield, A

BACKGROUND—Many patients continue to take regular β agonists, often at high doses, contrary to national and international guidelines. Some studies have suggested that this can worsen asthma control, but whether such patients can reduce their dose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c3616e0db61aee494ed9c3f560744d1a
https://europepmc.org/articles/PMC1745419/

Zobrazit plný text záznamu